HBV in Pregnancy
Release Date: January 15, 2009
Expiration Date: January 15, 2011
 |
||
|
How to Obtain AMA PRA
|
|
 |
||
Estimated Time of Completion: 15 minutes
Description
This webcast presents an overview of management of Hepatitis B in the pregnant woman, both for her well-being and to minimize the risk of infection in the new born. It includes a case, expert presentation, and panel discussion. This webcast was a part of the series filmed in front of a live audience on December 6, 2008, in Cleveland, Ohio.
Objectives
At the conclusion of this activity, the participant will be able to:
- Review data on risks for HBV transmission in pregnancy.
- Discuss treatment results for pregnancy.
Target Audience
This webcast is directed to hepatologists, gastroenterologists, infectious disease physicians, primary care physicians, infectious disease and gastroenterology nurse practitioners, infection control nurses, physician assistants, and others involved with the health care of HBV-infected patients or those at increased risk for acquiring the infection.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the
Accreditation Council for Continuing Medical Education to provide continuing medical
education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Director William Carey, MDProfessor of Medicine Cleveland Clinic Lerner College of Medicine Department of Gastroenterology & Hepatology Digestive Disease Institute Cleveland Clinic |
Presenting Faculty
 Tram Tran, MDAssistant Professor of Medicine, Geffen UCLA School of Medicine Medical Director, Liver Transplant Cedars Sinai Medical Center Los Angeles, California |
Panel
| William Carey, MD Professor of Medicine Cleveland Clinic Lerner College of Medicine Department of Gastroenterology & Hepatology Digestive Disease Institute Cleveland Clinic |
Pierre Gholam, MD Assistant Professor of Medicine Case Western Reserve University Division of Gastroenterology & Hepatology Case Medical Center University Hospitals of Cleveland Cleveland, Ohio |
| Robert Gish, MD Medical Director Liver Transplant Program Chief, Division of Hepatology and Complex GI California Pacific Medical Center Associate Clinical Professor of Medicine University of California San Francisco San Francisco, California |
Morris Sherman, MB BCh, PhD Associate Professor of Medicine University of Toronto The University Health Network in Toronto, Canada Toronto, Canada |
| Tram Tran, MD Assistant Professor of Medicine, Geffen UCLA School of Medicine Medical Director, Liver Transplant Cedars Sinai Medical Center Los Angeles, California |
Faculty Disclosure
In accordance with the Standards for Commercial Support issued by the Accreditation
Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation
Center for Continuing Education requires resolution of all faculty conflicts of interest to
ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
| Pierre Gholam, MD | |||
| Consultant, Teaching and Speaking: | Gilead Sciences, Inc.; Onyx Pharmaceuticals | ||
| Independent Contractor: | Gilead Sciences, Inc.; Onyx Pharmaceuticals; Sanofi-Aventis | ||
| Robert Gish, MD | |||
| Consultant: | Anadys Pharmaceuticals, Inc.; Bayer AG, BMS; Gilead Sciences, Inc.; GlaxoSmithKline; GlobelImmune; Hepahope; Human Genome Sciences; Idenix/Novartis; Innogenetics; Merck; Metabasis Therapeutics; Nucleonics; Pharmasset; Roche Laboratories, Inc.; Schering-Plough; SciClone Pharmaceuticals; Valeant Pharmaceuticals; Zymogenetics, Inc. | ||
| Grant/Research Support: | Bayer-Onyx; BMS; Gilead Sciences, Inc.; GlobelImmune; Idenix/Novartis; Merck; Nucleonics; Pfizer; Roche Laboratories, Inc.; Schering-Plough; SciClone Pharmaceuticals; Valeant Pharmaceuticals | ||
| Teaching and Speaking: | BMS; Gilead Sciences, Inc; GlaxoSmithKline; Ortho Biotech Products; Roche Laboratories, Inc. Salix Pharmaceuticals, Inc.; Schering-Plough; Three Rivers Pharmaceuticals | ||
| Morris Sherman, MB BCh, PhD | |||
| Consulting, Teaching and Speaking: | BMS, Gilead Sciences, Inc.; Roche Laboratories, Inc. | ||
The following faculty has indicated he/she has no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
William Carey, MD
Tram Tran, MD
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this activity from:
Bristol-Myers Squibb Company
Gilead Sciences, Inc.
This CME activity was produced by The Cleveland Clinic Foundation
Center for Continuing Education and UNITECH Communications®.
